Arax Advisory Partners’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$50.3K Buy
659
+605
+1,120% +$46.3K ﹤0.01% 3258
2026
Q1
$4.37K Sell
54
-9
-14% -$750 ﹤0.01% 2850
2025
Q4
$4.81K Sell
63
-544
-90% -$41.7K ﹤0.01% 2879
2025
Q3
$48.3K Buy
607
+600
+8,571% +$44.9K ﹤0.01% 1850
2025
Q2
$491 Sell
7
-7
-50% -$513 ﹤0.01% 2933
2025
Q1
$1.03K Sell
14
-77
-85% -$5.43K ﹤0.01% 2294
2024
Q4
$6.31K Hold
91
﹤0.01% 1660
2024
Q3
$7.65K Sell
91
-6
-6% -$462 ﹤0.01% 1526
2024
Q2
$6.57K Buy
97
+84
+646% +$5.39K ﹤0.01% 1468
2024
Q1
$817 Hold
13
﹤0.01% 1183
2023
Q4
$727 Hold
13
﹤0.01% 1177
2023
Q3
$668 Hold
13
﹤0.01% 1203
2023
Q2
$682 Hold
13
﹤0.01% 1166
2023
Q1
$671 Hold
13
﹤0.01% 1154
2022
Q4
$679 Hold
13
﹤0.01% 1137
2022
Q3
$1K Hold
13
﹤0.01% 1119
2022
Q2
$1K Hold
13
﹤0.01% 1082
2022
Q1
$1K Hold
13
﹤0.01% 1060
2021
Q4
$1K Buy
+13
New +$719 ﹤0.01% 1045

Other funds holding NHI

Arax Advisory Partners's NHI Position: Q2 2026 in Review

Arax Advisory Partners increased its National Health Investors (NHI) stake by 1,120% in Q2 2026, buying an estimated $46.3K and bringing the position to 659 shares worth $50.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3258.

Arax Advisory Partners first reported a position in NHI in Q4 2021 and has held it in 19 quarters since. 303 funds tracked by Wall St. Rank hold NHI as of Q2 2026.

  • Arax Advisory Partners held 659 shares of National Health Investors worth $50.3K as of Q2 2026.
  • Arax Advisory Partners bought 605 National Health Investors shares in Q2 2026, an estimated $46.3K.
  • National Health Investors made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3258 holding.
  • Arax Advisory Partners first reported a position in National Health Investors in Q4 2021 and has held it in 19 quarters since.
  • 303 funds tracked by Wall St. Rank held National Health Investors as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.